ManaT Bio
Baltimore, US · Founded 2020 · Delaware corporation
Founders & leadership
CG
Cary G. PfefferNamed on SEC filing
RJ
R. Jacob VogelsteinNamed on SEC filing
AV
Andrea Van ElsasNamed on SEC filing
RC
Raymond CamahortNamed on SEC filing
JN
Jack NielsenNamed on SEC filing
AP
Andrew PardollNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$72.1M disclosed across 1 round · 2023
▶$72.1MraisedOct 2023 · 9 investors · BiotechnologyRule 506(b)
▶$72.1MraisedOct 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cary G. PfefferExecutive Officer, Director
- R. Jacob VogelsteinDirector
- Andrea Van ElsasExecutive Officer, Director
- Raymond CamahortDirector
- Jack NielsenDirector
- Andrew PardollDirector
- ManaT Holdings, LLCPromoter
- Offering amount
- $153M
- Amount sold
- $72.1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ManaT Bio raised?
- ManaT Bio has disclosed $72.1M raised across 1 round.
- Where is ManaT Bio headquartered?
- ManaT Bio is headquartered in Baltimore, US.